News | January 31, 2022
Sun Pharma Q3FY22 PAT at Rs 2058.8 cr.
Sun Pharmaceutical Industries has reported consolidated financial results for the period ended December 31, 2021
Sun Pharmaceutical Industries has reported consolidated financial results for the period ended December 31, 2021
DS-5670 is an mRNA vaccine against Covid-19 using a novel nucleic acid delivery technology discovered by the company
ICICI Direct analysis of Dr Reddy’s Q3FY22 results
ABDM is a digital framework that will connect patients, doctors and other healthcare stakeholders nationwide to facilitate safe and secure movement of health information
The audit is a PAI for two of its product applications filed from this facility
In the April-September 2021 period, the FDI inflows continued to be buoyant at Rs 4,413 crore, growing at the rate of 53 per cent over the same period in 2020-21
Medtech plays a vital role in the healthcare system and players in this field believe that the budget should address some of their concerns if India has to become a formidable player
The aim is to strengthen industry-academia cooperation
Intranasal vaccines are easier to administer in mass immunisation campaigns and help reduce or stop transmission
The new centre will comprise a team of 50 highly experienced specialists
Subscribe To Our Newsletter & Stay Updated
